Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG, Boysen AK, Pallisgård N, Johansen JS, Tabernero J, Sørensen MM, Jensen BV, Hansen TF, Sefrioui D, Andersen RF, Brandslund I, Jakobsen A. Spindler KG, et al. Among authors: johansen js. Oncologist. 2017 Sep;22(9):1049-1055. doi: 10.1634/theoncologist.2016-0178. Epub 2017 Aug 4. Oncologist. 2017. PMID: 28778958 Free PMC article. Review.
Serum YKL-40, a new prognostic biomarker in cancer patients?
Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Johansen JS, et al. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):194-202. doi: 10.1158/1055-9965.EPI-05-0011. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492905 Review.
Is YKL-40 a new therapeutic target in cancer?
Johansen JS, Jensen BV, Roslind A, Price PA. Johansen JS, et al. Expert Opin Ther Targets. 2007 Feb;11(2):219-34. doi: 10.1517/14728222.11.2.219. Expert Opin Ther Targets. 2007. PMID: 17227236 Review.
Plasma YKL-40: a potential new cancer biomarker?
Johansen JS, Schultz NA, Jensen BV. Johansen JS, et al. Future Oncol. 2009 Sep;5(7):1065-82. doi: 10.2217/fon.09.66. Future Oncol. 2009. PMID: 19792974 Review.
Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.
Schultz NA, Christensen IJ, Werner J, Giese N, Jensen BV, Larsen O, Bjerregaard JK, Pfeiffer P, Calatayud D, Nielsen SE, Yilmaz MK, Holländer NH, Wøjdemann M, Bojesen SE, Nielsen KR, Johansen JS. Schultz NA, et al. Among authors: johansen js. PLoS One. 2013 Jun 26;8(6):e67059. doi: 10.1371/journal.pone.0067059. Print 2013. PLoS One. 2013. PMID: 23840582 Free PMC article.
MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS. Schultz NA, et al. Among authors: johansen js. JAMA. 2014 Jan 22-29;311(4):392-404. doi: 10.1001/jama.2013.284664. JAMA. 2014. PMID: 24449318
309 results